The implementation of the Modernization of Cosmetics Regulation Act (MoCRA) introduced a mandatory framework for cosmetic facility registration with the US FDA. At the center of this requirement is Form FDA 5066, the official submission mechanism used to register cosmetic manufacturing and processing facilities.
Form FDA 5066 is not simply an administrative form. It represents a legal declaration to the US FDA about who is manufacturing cosmetics, where production occurs, and what types of activities are being performed. Accurate and timely submission of Form FDA 5066 is essential for maintaining access to the US cosmetic market.
XPRO America operates as a professional US FDA Consultancy, assisting cosmetic companies worldwide with Form FDA 5066 preparation, submission, and ongoing compliance management.
What Is Form FDA 5066
Form FDA 5066 is the electronic registration form used to submit cosmetic facility registration information to the US FDA.
It supports MoCRA’s objective of creating a centralized database of cosmetic manufacturing and processing facilities that supply the US market.
Through Form FDA 5066, companies formally notify the US FDA of:
- Facility identity
- Location
- Operational activities
- Product categories handled
Once submitted, the facility becomes recognized within the US FDA regulatory system.
When Form FDA 5066 Is Required
Form FDA 5066 must be submitted when:
- A cosmetic facility begins manufacturing or processing products for the US market
- An existing facility must comply with MoCRA registration obligations
- Facility information changes
- Registration renewal is due
Without a valid Form FDA 5066 submission, a facility is considered unregistered and non-compliant.
Facilities That Must File Form FDA 5066
The following facilities are required to submit Form FDA 5066:
- US-based cosmetic manufacturers
- US-based cosmetic processors
- Foreign cosmetic manufacturers exporting to the United States
- Foreign cosmetic processors exporting to the United States
Both contract manufacturers and brand-owned facilities may have registration obligations.
Facilities That May Be Exempt
Some small businesses may qualify for limited exemptions based on annual sales thresholds or activities performed. However, exemption determinations are technical and must be evaluated carefully.
XPRO America reviews business operations to determine exemption eligibility before registration.
Information Collected in Form FDA 5066
A complete Form FDA 5066 submission typically includes:
- Legal facility name
- Physical facility address
- Mailing address (if different)
- Contact person information
- Type of cosmetic activities (manufacturing, processing, etc.)
- Cosmetic product categories handled
- US Agent information (for foreign facilities)
Errors or omissions may delay acceptance or trigger regulatory follow-up.
US Agent Requirement for Foreign Facilities
Foreign cosmetic facilities must designate a US Agent within Form FDA 5066.
The US Agent:
- Serves as the domestic point of contact for the US FDA
- Receives regulatory communications
- Facilitates information exchange
XPRO America provides US Agent services as part of its US FDA Consultancy offerings.
How Form FDA 5066 Fits Into MoCRA Compliance
Form FDA 5066 is one element of a broader compliance structure that includes:
- Cosmetic product listing
- Safety substantiation
- GMP implementation
- Labeling compliance
- Adverse event reporting
Facility registration and product listing are linked. A product cannot be properly listed unless its manufacturing facility is registered.
Submission Method
Form FDA 5066 is submitted electronically through the US FDA’s Cosmetics Direct system.
Paper submissions are not accepted.
XPRO America manages electronic submissions and confirmation tracking for clients.
Registration Renewal and Updates
Form FDA 5066 registrations must be:
- Renewed every two years
- Updated within 60 days of changes such as:
- Facility name
- Address
- Ownership
- Operational activities
Failure to maintain current information can result in non-compliance.
Common Errors With Form FDA 5066
- Incorrect facility address
- Missing US Agent information
- Inconsistent business names
- Selecting wrong activity types
- Failure to renew registration
These mistakes can lead to enforcement risk.
Regulatory Consequences of Not Filing Form FDA 5066
If a facility fails to register:
- Products may be considered non-compliant
- Imports may be refused
- Companies may receive warning letters
- Mandatory recalls may occur
- Business operations may be disrupted
Proactive registration prevents these outcomes.
Operational Advantages of Proper Facility Registration
Companies that properly file Form FDA 5066 benefit from:
- Faster product listing approval
- Reduced import delays
- Improved regulatory credibility
- Stronger distributor confidence
- Lower enforcement risk
Registration becomes a strategic asset.
How XPRO America Supports Form FDA 5066 Compliance
XPRO America operates as a trusted US FDA Consultancy providing:
- Form FDA 5066 preparation
- Facility registration submission
- US Agent services
- Compliance status review
- Renewal tracking
- Regulatory correspondence handling
For professional assistance, contact support@xproamerica.com.
Strategic Takeaway
Form FDA 5066 is the foundation of cosmetic facility registration under MoCRA. Companies that treat this requirement seriously build a stable compliance base that supports long-term access to the US cosmetic market.
With guidance from XPRO America, cosmetic manufacturers and processors can complete Form FDA 5066 correctly, maintain compliance, and operate confidently under US FDA regulations.
Leave a Reply